466 related articles for article (PubMed ID: 26744291)
21. Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report.
Ryhänen EM; Schalin-Jäntti C; Matikainen N
Front Endocrinol (Lausanne); 2021; 12():686135. PubMed ID: 34149623
[TBL] [Abstract][Full Text] [Related]
22. Craniofacial hemangiopericytoma associated with oncogenic osteomalacia: case report.
Sandhu FA; Martuza RL
J Neurooncol; 2000; 46(3):241-7. PubMed ID: 10902855
[TBL] [Abstract][Full Text] [Related]
23. Tumor induced osteomalacia.
Filipová L; Lazúrová I
Vnitr Lek; 2021; 67(E-8):19-22. PubMed ID: 35459330
[TBL] [Abstract][Full Text] [Related]
24. Tumor-induced Osteomalacia: A Systematic Review and Individual Patient's Data Analysis.
Rendina D; Abate V; Cacace G; D'Elia L; De Filippo G; Del Vecchio S; Galletti F; Cuocolo A; Strazzullo P
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3428-e3436. PubMed ID: 35468192
[TBL] [Abstract][Full Text] [Related]
25. Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23.
Nasu T; Kurisu S; Matsuno S; Tatsumi K; Kakimoto T; Kobayashi M; Nakano Y; Wakasaki H; Furuta H; Nishi M; Sasaki H; Suzuki H; Ito N; Fukumoto S; Nanjo K
Intern Med; 2008; 47(10):957-61. PubMed ID: 18480582
[TBL] [Abstract][Full Text] [Related]
26. Tumour-induced osteomalacia: the long road to diagnosis and recovery.
Vollmer S; Olsson K
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38697682
[TBL] [Abstract][Full Text] [Related]
27. Tumor-induced osteomalacia: experience from a South American academic center.
González G; Baudrand R; Sepúlveda MF; Vucetich N; Guarda FJ; Villanueva P; Contreras O; Villa A; Salech F; Toro L; Michea L; Florenzano P
Osteoporos Int; 2017 Jul; 28(7):2187-2193. PubMed ID: 28341900
[TBL] [Abstract][Full Text] [Related]
28. Tumour-induced osteomalacia due to residual benign glomangioma.
Barai R; Tsang T; Cespedes L
BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36357106
[TBL] [Abstract][Full Text] [Related]
29. Tumor-induced osteomalacia.
Jan de Beur SM
JAMA; 2005 Sep; 294(10):1260-7. PubMed ID: 16160135
[TBL] [Abstract][Full Text] [Related]
30. Intracranial phosphaturic mesenchymal tumors: report of 2 cases.
Mathis DA; Stehel EJ; Beshay JE; Mickey BE; Folpe AL; Raisanen J
J Neurosurg; 2013 Apr; 118(4):903-7. PubMed ID: 23350780
[TBL] [Abstract][Full Text] [Related]
31. Dual paraneoplastic syndromes: small cell lung carcinoma-related oncogenic osteomalacia, and syndrome of inappropriate antidiuretic hormone secretion: report of a case and review of the literature.
Tantisattamo E; Ng RC
Hawaii Med J; 2011 Jul; 70(7):139-43. PubMed ID: 21886301
[TBL] [Abstract][Full Text] [Related]
32. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
[TBL] [Abstract][Full Text] [Related]
33. Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia - diagnostic challenges and clinical outcomes.
Dutta D; Pandey RK; Gogoi R; Solanki N; Madan R; Mondal A; Dogra S; Thapa P
Endokrynol Pol; 2018; 69(2):205-210. PubMed ID: 29442350
[TBL] [Abstract][Full Text] [Related]
34. Tumour-induced osteomalacia: An emergent paraneoplastic syndrome.
Alonso G; Varsavsky M
Endocrinol Nutr; 2016 Apr; 63(4):181-6. PubMed ID: 26718193
[TBL] [Abstract][Full Text] [Related]
35. [Hypophosphatemic osteomalacia].
Bullmann C; Benker G; Rosien U; Delling G; Siggelkow H; Schulte HM
Med Klin (Munich); 2008 Sep; 103(9):671-5. PubMed ID: 18813890
[TBL] [Abstract][Full Text] [Related]
36. Tumor-induced osteomalacia: An overview.
Jadhav SS; Shah R; Patil V
Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101834. PubMed ID: 37935612
[TBL] [Abstract][Full Text] [Related]
37. [Oncogenic hypophosphatemic osteomalacia].
Schultze G; Delling G; Faensen M; Haubold R; Loy V; Molzahn M; Pommer W; Semler J; Trempenau B
Dtsch Med Wochenschr; 1989 Jul; 114(27):1073-8. PubMed ID: 2737097
[TBL] [Abstract][Full Text] [Related]
38. Tumor-induced osteomalacia combined with increased bone resorption postoperatively: A case report.
Shi L; Tang M; Duan S; Deng F; Zhang Y; Yang J; Hu J
Medicine (Baltimore); 2023 Jul; 102(27):e34217. PubMed ID: 37417620
[TBL] [Abstract][Full Text] [Related]
39. Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia.
Duet M; Kerkeni S; Sfar R; Bazille C; Lioté F; Orcel P
Clin Nucl Med; 2008 Nov; 33(11):752-6. PubMed ID: 18936605
[TBL] [Abstract][Full Text] [Related]
40. Oncogenic osteomalacia -- hypophosphataemic spectrum from "benignancy" to "malignancy".
Chiam P; Tan HC; Bee YM; Chandran M
Bone; 2013 Mar; 53(1):182-7. PubMed ID: 23220596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]